Learning to quantify emphysema extent: What labels do we need?

Accurate assessment of pulmonary emphysema is crucial to assess disease severity and subtype, to monitor disease progression and to predict lung cancer risk. However, visual assessment is time-consuming and subject to substantial inter-rater variability and standard densitometry approaches to quantify emphysema remain inferior to visual scoring. We explore if machine learning methods that learn from a large dataset of visually assessed CT scans can provide accurate estimates of emphysema extent. We further investigate if machine learning algorithms that learn from a scoring of emphysema extent can outperform algorithms that learn only from a scoring of emphysema presence. We compare four Multiple Instance Learning classifiers that are trained on emphysema presence labels, and five Learning with Label Proportions classifiers that are trained on emphysema extent labels. We evaluate performance on 600 low-dose CT scans from the Danish Lung Cancer Screening Trial and find that learning from emphysema presence labels, which are much easier to obtain, gives equally good performance to learning from emphysema extent labels. The best classifiers achieve intra-class correlation coefficients around 0.90 and average overall agreement with raters of 78% and 79% on six emphysema extent classes versus inter-rater agreement of 83%.

Towards automatic pulmonary nodule management in lung cancer screening with deep learning

The introduction of lung cancer screening programs will produce an unprecedented amount of chest CT scans in the near future, which radiologists will have to read in order to decide on a patient follow-up strategy. According to the current guidelines, the workup of screen-detected nodules strongly relies on nodule size and nodule type. In this paper, we present a deep learning system based on multi-stream multi-scale convolutional networks, which automatically classifies all nodule types relevant for nodule workup. The system processes raw CT data containing a nodule without the need for any additional information such as nodule segmentation or nodule size and learns a representation of 3D data by analyzing an arbitrary number of 2D views of a given nodule. The deep learning system was trained with data from the Italian MILD screening trial and validated on an independent set of data from the Danish DLCST screening trial. We analyze the advantage of processing nodules at multiple scales with a multi-stream convolutional network architecture, and we show that the proposed deep learning system achieves performance at classifying nodule type that surpasses the one of classical machine learning approaches and is within the inter-observer variability among four experienced human observers.